Gynecology

Latest News



Among BRCA mutation carriers, risk-reducing bilateral salpingo-oophorectomy (RRSO) results in an 80% reduction in risk of ovarian cancer and a 50% reduction in risk of breast cancer if the surgery is performed before the onset of menopause.

Analysis of data from more than 2.2 million vaginal deliveries shows that episiotomy declined between 2006 and 2012 and nonmedical factors may have been at play. The findings were published in a Research Letter in JAMA.

An ADP-ribose polymerase (PARP) inhibitor has received accelerated approval from the US Food and Drug Administration (FDA) for treatment of women with heavily pretreated ovarian cancer associated with defective BRCA genes.

Women at risk of ovarian cancer and who are undergoing hysterectomy should be counseled about the possible benefits of salpingectomy, according to a new committee opinion from the American College of Obstetricians and Gynecologists.

On July 29, 2010, a 46-year-old obese primarily Spanish-speaking patient was admitted to a hospital by her private ob/gyn Dr. A for a total laparoscopic hysterectomy (TLH) and/or laparoscopically assisted vaginal hysterectomy (LAVH) that day.